Search
Tvardi Therapeutics Ord Shs
TVRDAdd to Watchlist
1.320USD
-0.250-15.92%
Close 09-23 16:00（ET）
16.49MMarket Cap
0.20P/E TTM
Tvardi Therapeutics Ord Shs (TVRD) Revenue Performance
Updated: Mar 31, 2025By Business
Revenue
Proportion
Annual
Annual
Quarterly
Other revenue
Collaborative revenue
Commercial supply revenue
Clinical compound revenue
License and milestone fees
Royalty revenue
FY2024
FY2021
Other revenue
4.33M(60.63%)
--(--)
Collaborative revenue
2.09M(29.23%)
706.00K(3.07%)
Commercial supply revenue
640.00K(8.97%)
701.00K(3.04%)
Clinical compound revenue
84.00K(1.18%)
398.00K(1.73%)
License and milestone fees
--(--)
21.22M(92.16%)
Royalty revenue
--(--)
--(--)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
FY2024
United States
7.14M(100.00%)